· In the 150-mg dosing group , 81% in the 12-week arm and 86% in the 24-week arm reached the same endpoint.
"The 75% response in the 24-week , 75-mg arm was not significantly different from the``unexpectedly high""65% response rate among the placebo patients, Fried said."